KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Return on Equity (2016 - 2025)

West Pharmaceutical Services' Return on Equity history spans 16 years, with the latest figure at 0.16% for Q3 2025.

  • For Q3 2025, Return on Equity fell 2.0% year-over-year to 0.16%; the TTM value through Sep 2025 reached 0.16%, down 2.0%, while the annual FY2024 figure was 0.17%, 4.0% down from the prior year.
  • Return on Equity for Q3 2025 was 0.16% at West Pharmaceutical Services, down from 0.17% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.28% in Q1 2022 and bottomed at 0.16% in Q3 2025.
  • The 5-year median for Return on Equity is 0.2% (2024), against an average of 0.22%.
  • The largest annual shift saw Return on Equity grew 10bps in 2021 before it fell -10bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.28% in 2021, then dropped by -22bps to 0.22% in 2022, then fell by -9bps to 0.2% in 2023, then decreased by -12bps to 0.18% in 2024, then fell by -9bps to 0.16% in 2025.
  • Per Business Quant, the three most recent readings for WST's Return on Equity are 0.16% (Q3 2025), 0.17% (Q2 2025), and 0.17% (Q1 2025).